Cellular processes by which proteins (self or foreign) are proteolytically processed into peptides, loaded onto major histocompatibility complex (MHC) molecules (class I or II), and displayed on the cell surface for recognition by T lymphocyte receptors, enabling T cell activation or tolerance decisions.

Principle

Antigen presentation links intracellular protein origin and processing pathway to the type of MHC display: cytosolic peptides are primarily presented on MHC class I to CD8+ T cells, while endosomal/exogenous peptides are presented on MHC class II to CD4+ T cells, with cross-presentation and alternative routing as qualified exceptions.

Demonstration

Illustrative scenario — Situation: A host cell is infected by an intracellular virus. Recognition: Viral proteins are degraded by the proteasome, peptides are transported into the endoplasmic reticulum and loaded onto MHC class I. Action: Infected cell displays peptide–MHC I complexes at the surface. Consequence: CD8+ T cells recognizing the complex can become activated and kill the infected cell or produce effector cytokines.

Misapplication

Assuming that any peptide bound to MHC necessarily elicits an effective T cell response; this ignores peptide–MHC stability, T cell repertoire, co-stimulatory signals, and central/peripheral tolerance that determine whether recognition leads to activation, anergy, or deletion.

Consequence

Accurate antigen presentation is necessary for adaptive cellular immunity, vaccine responses, and immune surveillance; altered presentation (e.g., reduced MHC expression, altered peptide processing) can permit immune evasion or contribute to autoimmunity depending on context.

Reversal

The general routing rule (cytosolic → MHC I; endosomal → MHC II) is qualified by cross-presentation, autophagy-mediated presentation, and non-classical MHC molecules that permit presentation outside the canonical pathways, changing which T cell subsets can respond.

Boundary

Clearly within: Proteasomal degradation of viral proteins with peptide loading onto MHC I and surface display. Boundary case: Phagocytosed bacterial proteins presented via cross-presentation on MHC I — depends on antigen-presenting cell type and processing route. Clearly outside: Antibody binding to a soluble antigen in plasma without peptide presentation by MHC.

Semantic Tension

Specific antigen display for T cell activation ↔ need to avoid self-reactivity (tolerance): presentation must reveal enough information to detect infection or abnormality while minimizing presentation of self-peptides that would provoke autoimmunity.

Synthesis

Antigen presentation is the molecular bridge between protein source and T cell decision: the intracellular routing and peptide–MHC context determine which T cell subsets can sense a peptide and whether the encounter leads to activation, suppression, or ignorance.